Work

Supplemental Figure 3 from CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

Year: 2023

Type: supplementary-materials

Abstract: Rituximab increases cytotoxicity mediated by unlicensed NK cells.

DOI: 10.1158/2326-6066.22537463.v1

Authors: Juan Du, Sandra Lopez-Verges, Brandelyn N. Pitcher, Jeffrey Johnson, Sin-Ho Jung, Lili Zhou, Katharine Hsu, Myron S. Czuczman, Bruce Cheson, Lawrence Kaplan, Lewis L. Lanier, Jeffrey M. Venstrom

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362539846

Cites:

Cited by:

Related to: 10